课题基金 / 基金详情

AG 1343 FOR HIV+ PATIENTS--EXTENSION OF PILOT STUDY

AG 1343 FOR HIV+ PATIENTS--EXTENSION OF PILOT STUDY
AG 1343 针对 HIV 患者——试点研究的扩展
批准号：
5219604
负责人：
Martin H Markowitz
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5219604
关键词：
AIDS therapy HIV infections antiAIDS agent antiviral agents clinical research dosage drug screening /evaluation human subject human therapy evaluation

项目摘要

项目成果

Martin H Markowitz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study is an extension of a pilot study in which AG-1343 was given at doses of 500mg, 600mg, and 750mg BID and in this study increased to 500mg, 750mg, and 1000mg TID for a period of 28 days. It will attempt to evaluate safety and antiviral activity when used as monotherapy for individuals with HIV who have had less than 1 year of conventional antiretroviral therapy and have a viral load of 20,000 copies (BDNA) before initiating treatment with AG-1343.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A preclinical assessment of monthly intramuscular GSK1265744, an InSTI, as PrEP
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
海外基金